Bromine in PDB 7ebh: Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13

Enzymatic activity of Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13

All present enzymatic activity of Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13:
2.7.11.2;

Protein crystallography data

The structure of Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13, PDB code: 7ebh was solved by T.Orita, S.Doi, T.Iwanaga, T.Adachi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	94.70 / 1.96
*Space group*	P 6₄
*Cell size a, b, c (Å), α, β, γ (°)*	109.347, 109.347, 84.167, 90, 90, 120
*R / R_free (%)*	19.9 / 20.2

Other elements in 7ebh:

The structure of Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13 also contains other interesting chemical elements:

Chlorine

(Cl)

1 atom

Bromine Binding Sites:

The binding sites of Bromine atom in the Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13 (pdb code 7ebh). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13, PDB code: 7ebh:

Bromine binding site 1 out of 1 in 7ebh

Go back to

Bromine Binding Sites List in 7ebh

Bromine binding site 1 out of 1 in the Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13

Mono view

Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Crystal Structure of Human Pyruvate Dehydrogenase Kinase 2 in Complex with Compound 13 within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Br506 b:41.0 occ:1.00	BR1	A:J0F506	0.0	41.0	1.0
	C2	A:J0F506	1.9	36.0	1.0
	C1	A:J0F506	2.9	33.9	1.0
	C5	A:J0F506	2.9	36.0	1.0
	C11	A:J0F506	3.5	35.5	1.0
	C6	A:J0F506	3.6	39.4	1.0
	CD1	A:LEU330	3.6	47.5	1.0
	CB	A:ASN255	3.7	37.3	1.0
	CG	A:ASN255	3.8	43.0	1.0
	CD1	A:LEU346	3.9	48.5	1.0
	CD2	A:LEU330	4.0	42.5	1.0
	N3	A:J0F506	4.0	35.9	1.0
	CD2	A:LEU346	4.0	44.4	1.0
	C4	A:J0F506	4.1	38.1	1.0
	OD1	A:ASN255	4.2	44.1	1.0
	ND2	A:ASN255	4.3	39.5	1.0
	CG	A:LEU330	4.4	43.6	1.0
	C12	A:J0F506	4.5	35.7	1.0
	CD2	A:LEU252	4.6	34.8	1.0
	CG	A:LEU346	4.6	45.3	1.0
	CD1	A:LEU303	4.8	45.2	1.0
	N7	A:J0F506	4.9	41.2	1.0

Reference:

T.Akaki, Y.Bessho, T.Ito, S.Fujioka, M.Ubukata, G.Mori, K.Yamanaka, T.Orita, S.Doi, T.Iwanaga, K.Ikegashira, Y.Hantani, I.Nakanishi, T.Adachi. Fragment-Based Lead Discovery to Identify Novel Inhibitors That Target the Atp Binding Site of Pyruvate Dehydrogenase Kinases. Bioorg.Med.Chem. V. 44 16283 2021.
ISSN: ESSN 1464-3391
PubMed: 34274549
DOI: 10.1016/J.BMC.2021.116283

Page generated: Thu Jul 11 03:44:24 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy